PT818454E - Derivados de benzimidazole com actividade anti-histaminica - Google Patents

Derivados de benzimidazole com actividade anti-histaminica

Info

Publication number
PT818454E
PT818454E PT97500099T PT97500099T PT818454E PT 818454 E PT818454 E PT 818454E PT 97500099 T PT97500099 T PT 97500099T PT 97500099 T PT97500099 T PT 97500099T PT 818454 E PT818454 E PT 818454E
Authority
PT
Portugal
Prior art keywords
benzimidazole derivatives
antihistaminic activity
antihistaminic
activity
benzimidazole
Prior art date
Application number
PT97500099T
Other languages
English (en)
Portuguese (pt)
Inventor
Aurelio Orjales
Victor Rubio
Maravillas Bordell
Original Assignee
Faes Farma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faes Farma Sa filed Critical Faes Farma Sa
Publication of PT818454E publication Critical patent/PT818454E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT97500099T 1996-06-04 1997-06-03 Derivados de benzimidazole com actividade anti-histaminica PT818454E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09601236A ES2124167B1 (es) 1996-06-04 1996-06-04 Nuevos derivados del bencimidazol con actividad antihistaminica.

Publications (1)

Publication Number Publication Date
PT818454E true PT818454E (pt) 2004-08-31

Family

ID=8295035

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97500099T PT818454E (pt) 1996-06-04 1997-06-03 Derivados de benzimidazole com actividade anti-histaminica

Country Status (27)

Country Link
US (1) US5877187A (cg-RX-API-DMAC7.html)
EP (1) EP0818454B1 (cg-RX-API-DMAC7.html)
JP (1) JP4218991B2 (cg-RX-API-DMAC7.html)
CN (1) CN1105716C (cg-RX-API-DMAC7.html)
AR (1) AR008386A1 (cg-RX-API-DMAC7.html)
AT (1) ATE264317T1 (cg-RX-API-DMAC7.html)
AU (1) AU725700B2 (cg-RX-API-DMAC7.html)
BR (1) BR9703276A (cg-RX-API-DMAC7.html)
CA (1) CA2206754C (cg-RX-API-DMAC7.html)
CZ (1) CZ289278B6 (cg-RX-API-DMAC7.html)
DE (2) DE69728608T2 (cg-RX-API-DMAC7.html)
DK (1) DK0818454T3 (cg-RX-API-DMAC7.html)
ES (1) ES2124167B1 (cg-RX-API-DMAC7.html)
FR (1) FR11C0023I2 (cg-RX-API-DMAC7.html)
HR (1) HRP970307B1 (cg-RX-API-DMAC7.html)
HU (1) HU227598B1 (cg-RX-API-DMAC7.html)
IN (1) IN186319B (cg-RX-API-DMAC7.html)
LU (1) LU91798I2 (cg-RX-API-DMAC7.html)
MX (1) MXPA97004127A (cg-RX-API-DMAC7.html)
NO (2) NO313195B1 (cg-RX-API-DMAC7.html)
PL (1) PL188908B1 (cg-RX-API-DMAC7.html)
PT (1) PT818454E (cg-RX-API-DMAC7.html)
RU (1) RU2182150C2 (cg-RX-API-DMAC7.html)
SI (1) SI0818454T1 (cg-RX-API-DMAC7.html)
TR (1) TR199700464A3 (cg-RX-API-DMAC7.html)
TW (1) TW438794B (cg-RX-API-DMAC7.html)
ZA (1) ZA974893B (cg-RX-API-DMAC7.html)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9911752A (pt) 1998-07-01 2001-04-03 Takeda Chemical Industries Ltd Agente de regulagem da função do receptor relacionado com a retinóide, derivados de oxazol, de imidazol e de tiazol, composto, processo para regular uma função de receptor relacionado com a retinóide, e, uso de um derivado
HUP0200749A3 (en) 1998-11-27 2003-03-28 Basf Ag Substituted benzimidazoles and their use as parp inhibitors and process for their preparation
ES2151442B1 (es) * 1999-01-11 2001-07-01 Espanola Prod Quimicos Nuevo derivado del bencenoetanol.
US6826561B2 (en) 2000-05-22 2004-11-30 Broadcom Corporation Method and apparatus for performing a binary search on an expanded tree
EP1505066B1 (en) * 2002-04-19 2006-12-06 Faes Farma, S.A. Polymorph of acid 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piperidinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic
RU2288917C2 (ru) * 2002-04-19 2006-12-10 Фаэс Фарма, С.А. Полиморф 4-[2-[4-[1-(2-этоксиэтил)-1h-бензимидазол-2-ил]-1-пиперидинил]этил]-альфа, альфа-диметилбензолуксусной кислоты, способ его получения, фармацевтический препарат на его основе и его применение
EP1511482B1 (en) * 2002-06-13 2006-11-15 Vertex Pharmaceuticals Incorporated 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
US20070188330A1 (en) * 2006-01-24 2007-08-16 Morhard Robert C System and method for detecting, monitoring, tracking and identifying explosive materials using ID marks
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
KR101123903B1 (ko) 2008-02-12 2012-03-23 주식회사유한양행 2-메틸-2'-페닐프로피온산 유도체의 제조 방법 및 이에 사용되는 신규한 중간체 화합물
JP2010013472A (ja) * 2009-09-09 2010-01-21 Faes Farma Sa 4−[2−[1−(2−エトキシエチル)−1H−ベンズイミダゾール−2−イル]−1−ピペリジニル]エチル]−α,α−ジメチルベンゼノ酢酸の多形体
CN102675101B (zh) * 2012-05-16 2014-01-29 王蕾 2-(4-卤乙基)苯基-2-甲基丙酸酯的制备方法及合成比拉斯汀的方法
CZ307500B6 (cs) 2012-08-15 2018-10-24 Zentiva, K.S. Způsob přípravy derivátu 2-methyl-2´-fenylpropionové kyseliny využívající nové intermediáty
WO2014149019A1 (en) * 2013-03-15 2014-09-25 Hercules Incorporated Composition and method of producing personal care compositions with improved deposition properties
CN103214454A (zh) * 2013-03-30 2013-07-24 北京万全德众医药生物技术有限公司 一种比拉斯汀晶型及制备方法
CN103214455B (zh) * 2013-03-30 2018-08-31 北京万全德众医药生物技术有限公司 一种比拉斯汀的制备方法
WO2014188453A2 (en) * 2013-05-24 2014-11-27 Msn Laboratories Private Limited Novel process for the preparation of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl) phenyl]-2-methylpropanoic acid
CN103351380B (zh) * 2013-06-30 2019-01-22 北京万全德众医药生物技术有限公司 一种制备比拉斯汀的方法
CN104447683A (zh) * 2013-09-12 2015-03-25 天津市汉康医药生物技术有限公司 一种稳定的比拉斯汀化合物
CN103896915A (zh) * 2014-04-01 2014-07-02 中国药科大学 苯并咪唑类衍生物、其制备方法及其在医药上的应用
EP3040334A1 (en) 2014-12-29 2016-07-06 Faes Farma, S.A. New benzimidazole derivatives as antihistamine agents
CN106349214B (zh) * 2015-07-13 2020-11-03 南京长澳医药科技有限公司 一种比拉斯汀杂质的制备方法
ES2600827B9 (es) * 2015-07-24 2018-03-28 Urquima, S.A Formas cristalinas de bilastina y procedimientos para su preparación
CN105272977A (zh) * 2015-09-19 2016-01-27 万全万特制药江苏有限公司 一种制备比拉斯汀中间体的方法
EP3170816A1 (en) 2015-11-20 2017-05-24 Faes Farma, S.A. Supersaturated compositions of benzimidazole compounds
EP3170817A1 (en) 2015-11-20 2017-05-24 Faes Farma, S.A. Co-crystals of benzimidazole compounds
WO2017167949A1 (en) 2016-04-01 2017-10-05 Krka, D.D., Novo Mesto Crystalline forms of bilastine
WO2017191651A1 (en) * 2016-05-05 2017-11-09 Msn Laboratories Private Limited, R & D Center Solid state forms of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl)phenyl]-2-methylpropanoic acid and process for preparation thereof
CN107365298A (zh) * 2017-03-14 2017-11-21 罗欣生物科技(上海)有限公司 一种2‑甲基‑2’‑苯基丙酸衍生物的制备方法
CN109456316A (zh) * 2017-09-06 2019-03-12 万全万特制药江苏有限公司 一种比拉斯汀杂质的制备方法
ES2813561T3 (es) 2017-09-07 2021-03-24 Tiefenbacher Alfred E Gmbh & Co Kg Composición farmacéutica en comprimido que comprende bilastina
DK3681475T3 (da) 2017-10-16 2021-02-01 Faes Farma Sa Vandige sammensætninger omfattende bilastin og mometason
PL3641735T3 (pl) 2017-12-18 2021-09-06 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Kompozycja farmaceutyczna tabletki zawierająca bilastynę w postaci 3 i rozpuszczalny w wodzie wypełniacz
ES2835287T3 (es) 2017-12-18 2021-06-22 Tiefenbacher Alfred E Gmbh & Co Kg Composición farmacéutica de comprimido que comprende la forma polimórfica 3 de bilastina y aluminometasilicato de magnesio
EP3915539A1 (en) 2018-01-18 2021-12-01 Faes Farma, S.A. Ophthalmic compositions comprising bilastine, a beta-cyclodextrin and at least one gelling agent
CN109081827A (zh) * 2018-11-06 2018-12-25 北京天弘天达医药科技股份有限公司 一种比拉斯汀的制备方法及应用
EP3725298A1 (en) 2019-04-16 2020-10-21 Faes Farma, S.A. Stable and preserved pharmaceutical compositions of bilastine
EP4188339A1 (en) 2020-07-30 2023-06-07 Faes Farma, S.A. Decongestant drug delivery system
CN112110893A (zh) * 2020-10-28 2020-12-22 山东齐环医药科技有限公司 一种比拉斯汀的制备方法
JP2023549381A (ja) 2020-11-18 2023-11-24 バイオファーマ・シナジーズ,エス.エル. 抗ヒスタミン活性化合物を含む口内分散性粉末組成物
CA3200779A1 (en) 2020-12-23 2022-06-30 Strusi ORAZIO LUCA A non-micronized bilastine composition
CA3243849A1 (en) 2022-02-17 2023-08-24 Faes Farma, S.A. COMPOSITION OF BILASTIN FOR ONCE-DAILY PARENTERAL ADMINISTRATION
WO2024224326A1 (en) * 2023-04-27 2024-10-31 Leiutis Pharmaceuticals Llp Liquid parenteral formulations of bilastine
WO2024224308A1 (en) * 2023-04-27 2024-10-31 Leiutis Pharmaceuticals Llp Liquid parenteral formulations of bilastine free of cyclodextrins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8904174D0 (en) * 1989-02-23 1989-04-05 British Bio Technology Compounds
EP0525129A4 (en) * 1990-04-13 1993-03-24 Smith-Kline Beecham Corporation Substituted benzimidazoles
ES2048109B1 (es) * 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
FI950467L (fi) * 1992-08-03 1995-03-31 Sepracor Inc Terfenadiinin metaboliitit ja niiden optisesti puhtaat isomeerit allergisten sairauksien hoitamiseksi
CN1168717C (zh) * 1993-06-25 2004-09-29 默里尔药物公司 用于制备抗组胺哌啶衍生物的新中间体

Also Published As

Publication number Publication date
PL320358A1 (en) 1997-12-08
PL188908B1 (pl) 2005-05-31
IN186319B (cg-RX-API-DMAC7.html) 2001-08-04
US5877187A (en) 1999-03-02
HU9700997D0 (en) 1997-07-28
EP0818454B1 (en) 2004-04-14
JPH1059961A (ja) 1998-03-03
CA2206754C (en) 2007-01-23
AU2467297A (en) 1997-12-11
EP0818454A1 (en) 1998-01-14
ES2124167A1 (es) 1999-01-16
BR9703276A (pt) 2004-08-17
MXPA97004127A (es) 2005-07-25
JP4218991B2 (ja) 2009-02-04
TR199700464A2 (xx) 1997-12-21
SI0818454T1 (en) 2004-08-31
CN1105716C (zh) 2003-04-16
HRP970307B1 (en) 2002-02-28
HU227598B1 (en) 2011-09-28
NO972525L (no) 1997-12-05
TR199700464A3 (tr) 1997-12-21
FR11C0023I2 (fr) 2012-03-16
AR008386A1 (es) 2000-01-19
HUP9700997A1 (hu) 1999-09-28
ES2124167B1 (es) 1999-09-16
NO2011008I2 (no) 2012-05-14
CZ172397A3 (en) 1997-12-17
ZA974893B (en) 1997-12-30
DE122011000006I1 (de) 2011-06-16
NO313195B1 (no) 2002-08-26
CZ289278B6 (cs) 2001-12-12
NO972525D0 (no) 1997-06-03
HRP970307A2 (en) 1998-04-30
DE69728608T2 (de) 2005-04-21
CA2206754A1 (en) 1997-12-04
TW438794B (en) 2001-06-07
ATE264317T1 (de) 2004-04-15
AU725700B2 (en) 2000-10-19
RU2182150C2 (ru) 2002-05-10
DE69728608D1 (de) 2004-05-19
FR11C0023I1 (cg-RX-API-DMAC7.html) 2011-08-19
CN1176964A (zh) 1998-03-25
LU91798I2 (fr) 2011-05-23
NO2011008I1 (no) 2011-06-06
DK0818454T3 (da) 2004-07-12

Similar Documents

Publication Publication Date Title
PT818454E (pt) Derivados de benzimidazole com actividade anti-histaminica
PT900210E (pt) Derivados azahexano heterociclicos com actividade antviral
PT994890E (pt) Derivados de benzimidazole
DE69525418D1 (de) Benzimidazol-derivate
PT1044977E (pt) Derivados de camptotecina com actividade antitumoral
DK0901474T3 (da) Arylpyrimidinderivater
ATE261942T1 (de) 6-phenylpyridinderivate
IS5860A (is) 4,4-bíarýlpíperidín afleiður með ópíóíð viðtaka virkni
NO981946D0 (no) Imidazoquinazolin-derivater
DE69732576D1 (de) Tetrahydrobenzindolon-derivate
FI970469L (fi) Bentsimidatsolijohdannaisia, joilla on dopaminerginen aktiivisuus
EE9900182A (et) 2-metoksüfenüülpiperasiini derivaadid
NO20005271L (no) Optisk aktive tetrahydrobenzindol-derivater
BR9604831A (pt) Derivados de benzimidazol
FI965181A7 (fi) Polyalkoholi-peptidijohdannaiset
NO970498D0 (no) Benzimidazolderivater med dopaminergisk aktivitet
KR970055988U (ko) 근접센서의 고정구조
ATA73396A (de) 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate
ATA69896A (de) 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate